Lack of skin test reactivity to common mycobacterial antigens in human immunodeficiency virus infected individuals with high CD4 counts

Thorax

Volumn 51, Issue 9, 1996, Pages 932-935

  Khoo, S H ^a,c   Wilkins, E G L ^a   Fraser, I S ^a   Hamour, A A ^a   Stanford, J L ^b  

^a NORTH MANCHESTER GENERAL HOSPITAL   (United Kingdom)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^c UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

HIV; Mycobacterium avium complex; Skin tests; Tuberculosis

Indexed keywords

CD4 ANTIGEN;

ADULT; AGED; ARTICLE; CELLULAR IMMUNITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMORAL IMMUNITY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM AVIUM; PRIORITY JOURNAL; SKIN TEST; T LYMPHOCYTE SUBPOPULATION; TUBERCULIN TEST; TUBERCULOSIS;

EID: 0029758821     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.51.9.932     Document Type: Article

References (21)

1. Tsang AY, Denner JC, Brennan PJ, McClatchy JK. Clinical and epidemiological importance of typing of Mycobacterium avium complex isolates. J Clin Microbiol 1992;30:479-84.
2. Horseburgh CR. Mycobacterium avium complex infection in the acquired immunodeficiency syndrome. N Engl J Med 1991;324:1332-8.
3. Lee BY, Chaterjee D, Bozic CM, Brennan PJ, Cohn DL, Bales JD, et al. Prevalence of serum antibody to the type-specific glycopeptidolipid antigens of Mycobacterium avium in human immunodeficiency virus-positive and -negative individuals. J Clin Micrbiol 1991;29:1026-9.
4. Benson CA, Ellner JJ. Mycobacterium avium complex infections and AIDS: advances in theory and practice. Clin Infect Dis 1993;17:7-20.
5. Chin DP, Hopewell PC, Yajko DM, Vitinghoff K, Horsburgh CR, Hadley WK, et al. Mycobacterium avium complex in the respiratory or gastrointestinal tract and the risk of M avium complex bacteremia in patients with human immunodeficiency virus infection. J Infect Dis 1994;164:289-44.
6. von Reyn CF, Waddell RD, Eaton T, Arbeit RB, Maslow JN, Barber TW, et al. Isolation of Mycobacterium avium complex from water in the United States, Finland, Zaire and Kenya. J Clin Microbiol 1933;31:3227-30.
7. von Reyn CF, Maslow JN, Barber TW, Falkinham JO, Arbeit RD. Persistent colonisation of potable water as a source of Mycobacterium avium infection in AIDS. Lancet 1994;343:1137-41.
8. Stanford JL, Grange JM. The meaning and structure of species as applied to mycobacteria. Tubercle 1974;55:143-52.
9. Shield MJ, Stanford JL, Paul RC, Carswell JW. Multiple skin testing of tuberculosis patients with a range of new tuberculins and a comparison with leprosy and Mycobacterium ulcerus infection. J Hyg 1977;78:331-8.
10. McManus IC, Lockwood DNJ, Stanford JL, Shaaban MA, Abdul Ati M, Bahr GM. Recognition of a category of responders to group ii, slow grower associated antigens amongst Kuwaiti senior school children. Tubercle 1988; 69:275-81.
11. Lockwood DNJ, McManus IC, Stanford JL, Thomas A, Abeysgunawardana DVP. Three types of response to mycobacterial antigens. Eur Respir Dis 1987;71:348-55.
12. Eden W Van, De Vries RRP, Stanford JL, Rook GAW. HLA DR-3 associated genetic control of response to multiple skin tests with new tuberculins. Clin Exp Immunol 1983;52:287-42.
13. Rook GAW, Al-Attiyah R. Cytokines and the Koch phenomenon. Tubercle 1991;72:13-20.
14. Hernandez-Munoz HE, Stanford JL. IgA and IgG antibodies to distinct serotypes of Mycobacterium avium in HIV seropositivity and AIDS. J Med Microbiol 1996(in press).
15. Bottasso OA, Ingledew N, Keni M, Morini J, Pividori JF, Rook GAW, et al. Cellular immune response to common mycobacterial antigens in subjects seropositive for Trypanosoma cruzi, Lancet 1994;344:1540-1.
16. Clerici M, Shearer GM. A TH1 TH2 switch is a critical step in the etiology of HIV infection. Immunol Today 1993; 14:107-11.
17. McIntyre G, Belsey E, Stanford JL. Taxonomic differences between Mycobacterium avium and M intracellulare elucidated in man by skin tests with three new tuberculins. Eur J Respir Dis 1986;69:146-52.
18. Blatt SP, Hendrix CW, Butzin CA, Freeman TM, Ward WW, Hensley RE, et al. Delayed-type hypersensitivity skin testing predicts progression to AIDS in HIV-infected patients. Ann Intern Med 1993;119:177-84.
19. Stanford JL, Terencio de las Aguas J, Torres P, Gervasioni B, Ravioli R. Studies on the effects of a potential immunotherapeutic agent in leprosy patients. Health Cooperation Papers 1988; 7:201-6.
20. Bahr GM, Shaaban MA, Gabriel M, Al-Shimali B, Siddiqui Z, Chugh TD, et al. Improved immunotherapy for pulmonary tuberculosis with Mycobacterium vaccae. Tubercle 1990;71:259-66.
21. Stanford JL, Onyebujoh PC, Rook GAW, Grange JM, Pozniak A. Old plague, new plague, and a treatment for both. AIDS 1993; 7:1275-7.